Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Annals of Neurology
|
September 8, 2000
Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction
P Gressens, M Baes, P Leroux, et al.
The Biochemical Journal
|
February 15, 2001
Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse
S Huyghe, M Casteels, A Janssen, et al.
Nature Genetics
|
December 17, 1997
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
P Carmeliet, L Moons, R Lijnen, et al.
European Journal of Biochemistry
|
July 15, 1996
Rat pristanoyl-CoA oxidase. cDNA cloning and recognition of its C-terminal (SQL) by the peroxisomal-targeting signal 1 receptor
J C Vanhooren, M Fransen, B de Béthune, et al.
Nature Genetics
|
September 1, 1997
A mouse model for Zellweger syndrome
M Baes, P Gressens, E Baumgart, et al.
Journal of Neuropathology and Experimental Neurology
|
April 10, 2002
The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation
M Baes, P Gressens, S Huyghe, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 23, 2006
Farnesylation of Pex19p is not essential for peroxisome biogenesis in yeast and mammalian cells
I M K Vastiau, E A Anthonio, M Brams, et al.
Nature Medicine
|
September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
S Heymans, A Luttun, D Nuyens, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Annals of Neurology
|
September 8, 2000
Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction
P Gressens, M Baes, P Leroux, et al.
The Biochemical Journal
|
February 15, 2001
Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse
S Huyghe, M Casteels, A Janssen, et al.
Nature Genetics
|
December 17, 1997
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
P Carmeliet, L Moons, R Lijnen, et al.
European Journal of Biochemistry
|
July 15, 1996
Rat pristanoyl-CoA oxidase. cDNA cloning and recognition of its C-terminal (SQL) by the peroxisomal-targeting signal 1 receptor
J C Vanhooren, M Fransen, B de Béthune, et al.
Nature Genetics
|
September 1, 1997
A mouse model for Zellweger syndrome
M Baes, P Gressens, E Baumgart, et al.
Journal of Neuropathology and Experimental Neurology
|
April 10, 2002
The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation
M Baes, P Gressens, S Huyghe, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 23, 2006
Farnesylation of Pex19p is not essential for peroxisome biogenesis in yeast and mammalian cells
I M K Vastiau, E A Anthonio, M Brams, et al.
Nature Medicine
|
September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
S Heymans, A Luttun, D Nuyens, et al.
Page
of 4